Kymera Therapeutics, Inc. (KYMR) Earnings
NASDAQ·Healthcare·Biotechnology
$115.71
-1.10%
Mkt Cap $9.66B
EPS — Estimate vs Actual
Mkt Cap
$9.66B
P/E
—
Fwd P/E
—
P/S
187.63
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$115.71
-1.10%
Mkt Cap $9.66B
Mkt Cap
$9.66B
P/E
—
Fwd P/E
—
P/S
187.63
Rev TTM
—
EPS TTM
-$3.58